Paper Details

  1. Home
  2. Paper Details

Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.

Author: , JamesM, LenneyW, McKayA J, PriceD, Tudur SmithC, WilliamsonP R

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Asthma is a common condition in children in the UK, affecting one in eight. Current management guidelines are based on adult models, lacking sound evidence specific to children. The MASCOT study aims to address this need by providing evidence-based guidelines for asthma management in children.
Paper Details　
Original Abstract of the Article :
Asthma affects one in eight children in the UK. National management guidelines have been available for many years but, unlike in adults, studies in children have been few, with their methodologies often based on inappropriate adult models. Sound medical evidence in support of the national guidelines...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781219/

データ提供：米国国立医学図書館（NLM）

Addressing the Lack of Evidence in Asthma Management for School-Age Children

Asthma affects millions of children worldwide, a condition that often presents unique challenges, especially in its management. This research addresses a critical gap in knowledge, namely the lack of robust scientific evidence supporting asthma management guidelines for school-age children. The MASCOT study was designed to fill this void by conducting a rigorously controlled randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy and safety of asthma treatments.

MASCOT Study: Illuminating New Pathways for Asthma Management

The study aimed to provide sound medical evidence to support national guidelines for asthma management in children. It serves as a beacon in the vast desert of medical research, guiding clinicians towards more effective and safe treatment options for this common childhood condition.

Navigating the Landscape of Asthma Treatment

The MASCOT study serves as a reminder of the importance of evidence-based medicine in pediatric healthcare. By rigorously assessing the efficacy and safety of asthma treatments in children, the study provides a roadmap for navigating the complexities of this condition, ultimately benefiting the well-being of young patients.

Dr.Camel's Conclusion

The MASCOT study exemplifies the crucial role of research in shaping better healthcare practices for children. Its findings will undoubtedly improve our understanding of asthma management in children, offering a compass to guide doctors towards more effective and safer treatments. This research underscores the significance of evidence-based medicine in addressing the unique needs of pediatric patients.

Date :
  1. Date Completed 2013-07-22
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

23380178

DOI: Digital Object Identifier

PMC4781219

Related Literature

Article Analysis
・Side Effects of salmeterol oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.